Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BridgeBio Pharma, Inc.(BBIO) | 5,089,611 | 5,089,611 | 0 | $389.30M | $377.95M | 79.35% | -$11.35M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,316,806 | 1,316,806 | 0 | $27.67M | $30.76M | 6.46% | +$3.09M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 1,472,331 | 1,555,664 | +83,333 | $23.09M | $25.59M | 5.37% | +$2.50M |
| Bicara Therapeutics Inc. (BCAX) | 568,919 | 568,919 | 0 | $9.57M | $11.32M | 2.38% | +$1.74M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 564,625 | 1,018,018 | +453,393 | $7.07M | $9.11M | 1.91% | +$2.04M |
| COMPASS Pathways plcADS(CMPS) | 1,198,418 | 1,432,336 | +233,918 | $8.27M | $7.92M | 1.66% | -$348.3K |
| Scholar Rock Holding Corporation(SRRK) | 77,031 | 77,031 | 0 | $3.39M | $3.79M | 0.80% | +$393.6K |
| Biomea Fusion, Inc.(BMEA) | 2,048,757 | 2,048,757 | 0 | $2.54M | $3.13M | 0.66% | +$594.1K |
| Eupraxia Pharmaceuticals Inc.(EPRX) | 0 | 325,000 | +325,000 | $0 | $2.35M | 0.49% | +$2.35M |
| UroGen Pharma Ltd.(URGN) | 108,000 | 108,000 | 0 | $2.53M | $1.94M | 0.41% | -$587.5K |
| Aclaris Therapeutics, Inc.(ACRS) | 434,455 | 434,455 | 0 | $1.31M | $1.63M | 0.34% | +$321.5K |
| Marker Therapeutics, Inc.(MRKR) | 325,370 | 325,370 | 0 | $484.8K | $423.0K | 0.09% | -$61.8K |
| OnKure Therapeutics, Inc.CL A(OKUR) | 88,607 | 88,607 | 0 | $257.0K | $366.8K | 0.08% | +$109.9K |
| CalciMedica, Inc.(CALC) | 521,114 | 0 | -521,114 | $3.43M | $0 | — | -$3.43M |